Cytochrome P450 2A6/7/13 Antibody , Cat. # DF10129

SKU: DF10129

Size:100ul

Host:Rabbit

Clonality:Polyclonal

Isotype:IgG

GeneName:CYP2A7,CYP2A6,CYP2A13

GeneID:1549,1548,1553

Uniprot:P11509/P20853/Q16696

Specificity:Cytochrome P450 2A6/7/13 Antibody detects endogenous levels of total Cytochrome P450 2A6/7/13.

Immunogen:A synthesized peptide derived from human Cytochrome P450 2A6/7/13, corresponding to a region within N-terminal amino acids.

Storage:Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt.

Reactivity:Human

Prediction:Sheep

Application:WB,ELISA(peptide)

Dilution:WB 1:1000-3000, ELISA(peptide) 1:20000-1:40000

Conjugate:Unconjugated

RRID:AB_2840709

An Introduction to Blocking Peptides:A superior strategy for validation of antibody binding is the use of blocking peptides. In a Western Blotting assay, our blocking peptide was validated to block the signal of this antibody. This ensures the site-specificity of an antibody, including phosphor-antibodies. In the case of the phosphor- antibodies, the antibodies can and will only recognize the phosphorylated target protein at the corresponding site, not the non-phosphorylated target protein or target protein phosphorylated at a different site.

Cat# Blocking Peptide:DF10129-BP

Des# Blocking Peptide:Cytochrome P450 2A6/7/13 Blocking peptide

Blocking Peptide Price:$549 CAD